HT Research Ethics Committee: open call for external members
The Research Ethics Committee (REC) of the Human Technopole Foundation is responsible for evaluating scientific research projects and activities undertaken at Human Technopole (HT) so that they are ethically reviewed, cleared and monitored in accordance with national and international ethical laws, norms, principles, guidelines, standards and best practices regulating scientific research.
The REC is composed of an odd number of members, from a minimum of 5 to a maximum of 11 members, the majority of which should be external to HT. Committee members shall be appointed by HT’s Management Committee and shall possess a recognised expertise in ethics or other knowledge domains relevant to the mission of HT and the tasks of the REC. The term of office of each REC member is four years, renewable once.
A call is currently open to select the external members of HT’s Research Ethics Committee. Further information is available in the Annexes below.
Interested candidates should send in their application, as described in Annex 1, by 5pm on 25 August 2023 by PEC at htechnopole@pec.fondazioneht.it digitally signed or, if not digitally signed, attaching a copy of a valid identity document.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.